Skip to main content

News

News
09/04/2025
"Plaque burden quantification by AI-QCT provides critical insights that standard CT evaluation will miss," said Principal investigator Alexander van Rosendael, MD, PhD, "especially in patients with mild to moderate disease who represent a...
"Plaque burden quantification by AI-QCT provides critical insights that standard CT evaluation will miss," said Principal investigator Alexander van Rosendael, MD, PhD, "especially in patients with mild to moderate disease who represent a...
"Plaque burden quantification by...
09/04/2025
Cath Lab Digest
PAD Pulse Alliance
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Pulmonary Embolism
09/04/2025
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use...
09/04/2025
Cath Lab Digest
beta blockers
09/04/2025
“This trial will reshape all international clinical guidelines. It joins other previous landmark trials led by CNIC and Mount Sinai—such as SECURE with the polypill and DapaTAVI, with SLT2 inhibition associated to TAVI—that have already...
“This trial will reshape all international clinical guidelines. It joins other previous landmark trials led by CNIC and Mount Sinai—such as SECURE with the polypill and DapaTAVI, with SLT2 inhibition associated to TAVI—that have already...
“This trial will reshape all...
09/04/2025
Cath Lab Digest
Hypertrophic cardiomyopathy
09/04/2025
The data further supports the growing body of evidence for Camzyos, a cardiac myosin inhibitor, as a standard of care for NYHA class II-III symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
The data further supports the growing body of evidence for Camzyos, a cardiac myosin inhibitor, as a standard of care for NYHA class II-III symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
The data further supports the...
09/04/2025
Cath Lab Digest
Renal Denervation
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
TAVR
08/28/2025
The FDA's approval allows for the implantation of a new Evolut transcatheter aortic valve (TAV) inside any failed previously implanted TAV and follows CE (Conformité Européenne) Mark for Evolut PRO+, FX and FX+ systems. 
The FDA's approval allows for the implantation of a new Evolut transcatheter aortic valve (TAV) inside any failed previously implanted TAV and follows CE (Conformité Européenne) Mark for Evolut PRO+, FX and FX+ systems. 
The FDA's approval allows for...
08/28/2025
Cath Lab Digest
News
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Uncontrolled Hypertension
08/26/2025
Atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy [CNT™]) is for the treatment of hypertension. AVIM therapy is currently being evaluated in the BACKBEAT global pivotal study.
Atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy [CNT™]) is for the treatment of hypertension. AVIM therapy is currently being evaluated in the BACKBEAT global pivotal study.
Atrioventricular interval...
08/26/2025
EP Lab Digest